News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

When to Stop Expensive, Successful Drug Trials, University of Colorado Reveals


8/9/2013 7:05:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Generally, FDA-approved clinical trials progress through three phases: the first shows safety, the second starts to explore effects and the third seeks to prove a drug’s superiority over existing treatments. But when a drug’s benefit is obvious in the first or second phase, is the third, costly phase needed? The question is posed in a recent edition of the journal Nature Reviews: Clinical Oncology by Robert C. Doebele, MD, PhD, investigator at the University of Colorado Cancer Center and assistant professor of medical oncology at the CU School of Medicine.

Hey, check out all the research scientist jobs. Post your resume today!

Read at ScienceBlog

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES